MimiVax

Buffalo, United States

MimiVax is a developer of immunotherapeutic vaccines and targeted therapies used to control tumor growth and recurrence.

Jan 2024

Venture - Series Unknown

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

Who are MimiVax's investors?

MimiVax's investors include MEDA Angels, Varia Ventures, Brain Tumor Investment Fund, Sontag Family Trust.

Where is MimiVax headquartered?

MimiVax is headquartered in Buffalo, United States.

What does MimiVax do?

MimiVax is a developer of immunotherapeutic vaccines and targeted therapies used to control tumor growth and recurrence.

What stage is MimiVax at?

MimiVax is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 9, 2024.

MLA

"MimiVax — Funding & Investors." VCBacked, January 9, 2024, https://www.vcbacked.co/company/mimivax. Accessed July 2, 2026.

APA

VCBacked. (2024). MimiVax — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/mimivax

Wikipedia (cite web)

{{cite web |title=MimiVax — Funding & Investors |url=https://www.vcbacked.co/company/mimivax |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 9, 2024.